DUBLIN--(BUSINESS WIRE)--The "A Practical Guide to Writing Risk Management Plans (RMPS)" conference has been added to Research and Markets' offering.
The new Pharmacovigilance Legislation of 2012 now requires companies to provide Risk Management Plans (RMPs) and assessments for all new products whether those products are generic products or new chemical entities.
If these are not done correctly this can delay both licensure and sales and damage the Company ability to maximise its products. Maintenance of the RMPs also is an important aspect for maintaining the licence, compliance and these are reviewed in Regulatory Inspections. Can you afford not to get this right?
This course will be relevant for anyone requiring a comprehensive overview of the Pharmacovigilance function and duties. It may be of particular interest to those who are responsible in Pharmacovigilance for any safety assessments and writing such plans including any Medical Directors who approve such plans.
Those who work with pharmacovigilance, e.g. Regulatory Affairs, Clinical, Sales & Marketing, Legal, Commercial and Quality and EU QP PVs that must sign off such documents.
Topics to be covered will include:
- An Introduction to ICH & EU RMPs - Production & Maintenance
- Documentation to be Supplied to Regulatory Authorities - the process for RMPs
- The EU Templates & their Completion - Generic and Innovator Products
- RMPs in other Countries
- Practical - Completion of Sections I - III
- Practical - Completion of Sections IV - VI
- Practical - Completion of Annexes
For more information about this conference visit https://www.researchandmarkets.com/research/qkh7m5/a_practical_guide